Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Thrombosis and Haemostasis

• Publication date

  2012-08-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH12-05-0303PMID 22872040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?

  2012cited by this paper
• Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model.

  2012cited by this paper
• Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.

  2012cited by this paper
• Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application

  2012cited by this paper
• Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes.

  2012cited by this paper
• Transplantation of adipose tissue-derived stem cells overexpressing heme oxygenase-1 improves functions and remodeling of infarcted myocardium in rabbits.

  2012cited by this paper
• A new heart: Somatic stem cells and myocardial regeneration

  2012cited by this paper
• Stem cell treatment for acute myocardial infarction.

  2012cited by this paper
• An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.

  2012cited by this paper
• A Central Role of Heme Oxygenase-1 in Cardiovascular Protection

  2011cited by this paper
• Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection

  2011cited by this paper
• Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats

  2011cited by this paper
• Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium

  2011cited by this paper
• Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction.

  2011cited by this paper
• Effects of heme oxygenase-1 gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts.

  2011cited by this paper
• Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences

  2011cited by this paper
• HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study

  2010cited by this paper
• Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.

  2010cited by this paper
• HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium.

  2010cited by this paper
• Cardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart

  2010cited by this paper
• Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium

  2010cited by this paper
• Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia.

  2010cited by this paper
• Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice

  2009cited by this paper
• Paracrine action of HO‐1‐modified mesenchymal stem cells mediates cardiac protection and functional improvement

  2008cited by this paper
• Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

  2008cited by this paper
• Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.

  2008cited by this paper
• Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction.

  2007cited by this paper
• Myocardial reperfusion injury.

  2007cited by this paper
• Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial

  2006cited by this paper
• Heme oxygenase‐1 (HO‐1) inhibits postmyocardial infarct remodeling and restores ventricular function

  2006cited by this paper
• Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice.

  2005cited by this paper
• Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector.

  2005cited by this paper
• Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium

  2005cited by this paper
• Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy

  2005cited by this paper
• Myocardial Reperfusion Injury

  2004cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003cited by this paper
• Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution

  2003cited by this paper
• Expression of heme oxygenase-1 in response to myocardial infarction in rats.

  2002cited by this paper

• Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych

  2024cites this paper
• miR-133a - a potential target for improving cardiac mitochondrial health and regeneration post injury.

  2022cites this paper
• Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy

  2022cites this paper
• The Impact of a Modified Anaesthetic Protocol on Animal Survival and the Characteristics of Ventricular Arrhythmias in the Course of Acute Myocardial Infarction in a Domestic Pig Model

  2022cites this paper
• The role of heme oxygenase-1 in hematopoietic system and its microenvironment

  2021cites this paper
• The Emerging Roles of the Gaseous Signaling Molecules NO, H2S, and CO in the Regulation of Stem Cells.

  2020cites this paper
• Murine Bone Marrow Mesenchymal Stromal Cells Respond Efficiently to Oxidative Stress Despite the Low Level of Heme Oxygenases 1 and 2

  2018cites this paper
• Title : Murine bone marrow mesenchymal stromal cells respond efficiently to oxidative stress despite the low level of heme oxygenases 1 and 2 Running title : Murine BM MSC are resistant to oxidative stress

  2017cites this paper
• Heart injury and repair: hopes and hypes of cell therapies and biomaterials

  2017cites this paper
• Critical View on Mesenchymal Stromal Cells in Regenerative Medicine

  2017cites this paper
• Generation of functional endothelial cells with progenitor-like features from murine induced pluripotent stem cells.

  2016influential citation
• Advances in stem cell therapy for cardiovascular disease (Review)

  2016cites this paper
• Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

  2016cites this paper
• Adult stem cells: hopes and hypes of regenerative medicine.

  2015cites this paper
• Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study

  2015cites this paper
• Developing an Advanced Therapy Medicinal Product (ATMP) for the treatment of GvHD

  2014cites this paper
• Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells

  2014cites this paper
• Heme Oxygenase-1 As a Target for Drug Discovery

  2014cites this paper
• Heme Oxygenase-1: A Metabolic Nike

  2014cites this paper
• Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies.

  2014cites this paper
• Curcumin-Induced Heme Oxygenase-1 Expression Prevents H2O2-Induced Cell Death in Wild Type and Heme Oxygenase-2 Knockout Adipose-Derived Mesenchymal Stem Cells

  2014cites this paper
• Angiogenesis and Vascularisation

  2013cites this paper
• Therapeutic angiogenesis for revascularization in peripheral artery disease.

  2013cites this paper
• Identifying MicroRNAs Involved in Degeneration of the Organ of Corti during Age-Related Hearing Loss

  2013cites this paper
• Nrf2 Transcription Factor and Heme Oxygenase-1 as Modulators of Vascular Injury and Angiogenesis

  2013cites this paper
• Vessel wall – where coagulation meets cell biology and immunology

  2012cites this paper